« Back to Blog
Introducing Devon Womack, The Network’s new president
By The Network’s editorial staff
As cancer care evolves at an increasingly rapid pace, The US Oncology Network stands at the forefront of community oncology, dedicated to advancing care and enhancing patient outcomes. Leading this charge is our new president Devon Dickey Womack, whose appointment marks a significant milestone in our journey towards setting new standards in oncology care. With an unwavering commitment and a visionary approach, she is poised to steer The Network through its next phase of growth and innovation, ensuring that we support practices as they continue to deliver best-in-class care.
With a 14-year tenure with The Network and McKesson, Devon is a familiar face and brings deep expertise and dynamic leadership to her new role. Most recently as the chief operating officer of The Network, she made great strides in ensuring practices have the resources they need to operate efficiently and deliver cost-effective, high-quality patient care. She led the launch of The Network’s “Time to First” strategy to improve patient access. Through this initiative, more than 70% of practices in The Network reduced the time for patients to complete their first consult with their oncologist.
Additionally, Devon continues to pave the way for research expansion with eleven practices in The Network entering into new research agreements with Sarah Cannon Research Institute (SCRI). We are already exceeding our initial treatment trial accruals goal, starting the fiscal year off strong. Our goal is to ensure that more patients have access to modern cancer therapies and treatment trials. Advancing cancer research to make these therapies a reality for everyone happens in the community setting.
Devon is deeply committed to the development and support of oncology practices and their ability to deliver top-tier care, aiming to support more than 25% of cancer patients across the nation. Under her leadership, The Network is continuing to double down on its focus on patient care models that encompass not only state-of-the-art treatments but also psychological and social support for patients and their families.
As she takes the helm of The Network, Devon is enthusiastic about the potential for transformative change in community oncology. Her vision encompasses a broad spectrum of initiatives aimed at enhancing patient care through technological innovation, precision medicine, operational excellence and practice growth.
“There is much to be optimistic about in the future of community oncology. Our commitment lies in providing cutting-edge care, right in your own backyard,” says Devon. “Together, we will ensure that patients receive world-class treatment, while fostering an environment where practices, physicians and care teams can thrive and make a lasting impact on their communities.”
As we embark on this exciting new chapter under Devon’s leadership, The Network is positioned not only to meet the current demands of oncology care but to anticipate and respond to future challenges. Her strategic vision, coupled with a relentless dedication to excellence, will guide The Network as the leader in community oncology, setting the standard for care, compassion and innovation.
